1. Background {#sec61971}
=============

Meningitis is an inflammation of the membranes (meninges) surrounding the brain and spinal cord. The disease can be caused by viral or bacterial pathogens ([@A17616R1], [@A17616R2]). Most cases of bacterial meningitis occur in childhood and its pathogens are varied in different age groups ([@A17616R3]). *Streptococcus pneumoniae*, *Neisseria meningitidis*, and *Haemophilus influenzae*type b are among the prevalent bacterial pathogens of this disease ([@A17616R4]-[@A17616R6]). In recent years, two main changes have been observed in the epidemiology of acute bacterial meningitis ([@A17616R7]). The first is a decrease in the incidence of *H. influenzae* type b and *S. pneumoniae*meningitis in countries where vaccination plan is generally performed against the two bacteria ([@A17616R8]-[@A17616R10]). The second is an increase in resistant strains of pneumococcus across the world ([@A17616R11]-[@A17616R13]). Due to the lack of vaccination against these pathogens in the area under study, acute bacterial meningitis is a fatal urgency with high rate of mortality and serious potential effects ([@A17616R14]). Therefore, early diagnosis and appropriate antibiotic therapy are necessary to avoid further complications. However, the occurrence and etiologies of bacterial meningitis vary in different geographic regions. Moreover, effectiveness of treatment is limited due to antibiotic resistant bacterial strains ([@A17616R4], [@A17616R15]).

The epidemiology of bacterial meningitis has not been well characterized in our country so far. Furthermore, to make decision regarding children\'s vaccination against causative bacteria in our country, it is required to know the outbreak of the bacterial meningitis in the area. On the other hand, to make proper decision concerning the treatment of bacterial meningitis, we need to recognize antibiotic resistance patterns of prevalent bacteria in the area. This study is the first comprehensive study to assess bacterial meningitis in northwest of Iran.

2. Objectives {#sec61972}
=============

The present study was performed to investigate the etiological profile and antimicrobial resistance patterns of bacterial isolates of meningitis in children in northwest of Iran to improve evidence-based therapeutic strategies.

3. Patients and Methods {#sec61977}
=======================

3.1. Study Population and Data Collection {#sec61973}
-----------------------------------------

In a retrospective study, of 7112 suspected cases of meningitis admitted to Tabriz Children Educational-Health Care Center (the only Children's referral hospital in northwest of Iran) between April 2003 and March 2013, a total of 107 cerebrospinal fluid (CSF) culture had positive results for a bacterial pathogen and included in the study. Our sampling was purposive. Patients were defined as having acute bacterial meningitis if the cerebrospinal fluid (CSF) culture had positive result for at least a bacterial pathogen. Permission was obtained from patients before inclusion in the study. Some information including age, weight, sex, clinical symptoms and history of illness were recorded at the time of admission. All patients' data were recorded and analyzed according to the considerations of university ethical committee.

3.2. Laboratory Methods {#sec61974}
-----------------------

Standard methods were used for the analysis and culture of CSF specimens collected from all suspected patients. Immediately after receipt, each CSF specimen was centrifuged at 1500 rpm for 15 minutes. The supernatant was removed and the sediment was cultured on 5% sheep blood agar and chocolate agar plates. Gram staining was also performed. Furthermore, blood cultures were performed for each patient on admission. All isolates were identified based on their colony, morphology, culture characteristics, and biochemical reactions according to the standard microbiological procedures ([@A17616R16]).

3.3. Antibiotic Susceptibility Tests {#sec61975}
------------------------------------

All isolates were examined for resistance to routine antimicrobial agents by standard disk diffusion method using *Staphylococcus aureus*(ATCC 25923) and *Escherichia coli* (ATCC 25922) as control strains ([@A17616R17]). The antibiotics tested were gentamicin, amikacin, ceftazidime, ceftizoxime, cefotaxime, ceftriaxone, imipenem, ciprofloxacin, co-trimoxazole, chloramphenicol, penicillin, oxacillin, ampicillin, vancomycin, rifampicin and erythromycin (Mast Co, the UK). Isolates showing intermediate levels of susceptibility were classified as nonsusceptible.

3.4. Statistical Analysis {#sec61976}
-------------------------

Data was analyzed using SPSS software version 13. Chi-square test was used to calculate rates and percentages. The significance level was defined as P \< 0.05.

4. Results {#sec61978}
==========

During the 10-year of this study, 107 cases with confirmed acute bacterial meningitis were reported based on positive results in culture of cerebrospinal fluid. Patients included 60 males (56.07%) and 47 females (43.93%) with at least 2 days to 13 years old (mean age = 4.2 years). Clinical manifestations during hospitalization are presented in [Table 1](#tbl15812){ref-type="table"}. Fever, vomiting, and meninges irritation were the most prevalent symptoms of patients. In the present study, the results of simultaneous blood culture were also examined. The most prevalent organism isolated from blood cultures was *H. influenzae* type b (20.65%). While, *S. pneumonia* (34.5%) and *H. influenzae* type b (23.36%) were the main bacteria isolated from CSF, respectively. The prevalence of other bacterial pathogens isolated from the patients\' CSF and blood cultures are listed in [Table 2](#tbl15813){ref-type="table"}. According to our results, 70.09% of patients were under 2 years, which 89.18% of them had pneumococcal meningitis (P = 0.001).

According to antimicrobial susceptibility testing, most species were identified to have relatively high resistance against some conventional antibiotics including the third-generation cephalosporins. [Table 3](#tbl15814){ref-type="table"} shows the antimicrobial resistance pattern of pathogens isolated from CSF culture.

###### Clinical Manifestations of Children With Acute Bacterial Meningitis

  Clinical Symptoms         Number of Patients   Occurrence (%)
  ------------------------- -------------------- ----------------
  **Fever**                 107                  100
  **Vomiting**              80                   74.76
  **Meninges irritation**   75                   70.09
  **Seizure**               43                   46.01
  **Headache**              17                   15.88
  **Lethargy**              41                   37.38
  **Stupor**                11                   10.28
  **Coma**                  7                    6.54

###### Isolated Organisms From CSF and Blood Cultures of Patients With Acute Bacterial Meningitis

  Microorganisms                                CSF, No. (%)   Blood, No. (%)
  --------------------------------------------- -------------- ----------------
  ***Streptococcus pneumoniae***                37 (34.5)      7 (6.54)
  ***Haemophilus influenzae***                  25 (23.36)     22 (20.65)
  ***Neisseria meningitidis***                  7 (6.54)       3 (2.8)
  ***Serratia*** **spp.**                       7 (6.54)       1 (0.93)
  ***Klebsiella pneumoniae***                   6 (5.6)        2 (1.86)
  ***Pseudomonas aeruginosa***                  4 (3.73)       1 (0.93)
  ***Escherichia coli***                        4 (3.73)       \-
  ***Staphylococcus aureus***                   4 (3.73)       1 (0.93)
  **Viridans** ***Streptococci***               4 (3.73)       1 (0.93)
  **Coagulase-Negative Staphylococci (CoNS)**   3 (2.8)        1 (0.93)
  ***Enterococcus*** **spp.**                   3 (2.8)        \-
  ***Acinetobacter*** **spp.**                  2 (1.86)       \-
  ***Salmonella*** **serogroup D**              1 (0.93)       \-

###### Antimicrobial Resistance (%) of Bacterial Pathogens Isolated From CSF Culture

  Antibiotics           *S. pneumoniae*   *H. influenzae*   *N. meningitidis*   *K. pneumoniae*   *E. coli*   *Serratia*spp.   *P. aeruginosa*   *S. aureus*   CoNS   *Viridans Streptococci.*   *Enterococcus*spp.   *Acinetobacter*spp.   *Salmonella*
  --------------------- ----------------- ----------------- ------------------- ----------------- ----------- ---------------- ----------------- ------------- ------ -------------------------- -------------------- --------------------- --------------
  **Ciprofloxacin**     8                 4                 0                   0                 25          15               60                50            \-     75                         66.66                50                    0
  **Gentamicin**        29.72             16                0                   87.5              50          57.14            40                50            75     100                        100                  100                   0
  **Amikacin**          35.13             24                0                   100               50          100              20                25            25     100                        100                  50                    0
  **Vancomycin**        0                 \-                \-                  \-                \-          \-               \-                0             0      25                         33.33                \-                    \-
  **Rifampicin**        2.7               28                \-                  \-                \-          \-               \-                25            25     50                         33.33                \-                    \-
  **Erythromycin**      16.21             \-                \-                  \-                \-          \-               \-                50            75     75                         100                  \-                    \-
  **Imipenem**          \-                0                 \-                  12.5              25          20               20                \-            \-     \-                         \-                   50                    \-
  **Co-trimoxazole**    32.43             20                0                   62.5              25          14.28            100               25            \-     75                         33.33                100                   100
  **Chloramphenicol**   5.4               0                 0                   12.5              50          57.14            60                75            \-     50                         33.33                100                   0
  **Ceftriaxone**       10.81             20                0                   62.5              100         85.71            60                75            75     25                         100                  100                   0
  **Cefotaxime**        8.1               28                0                   87.5              75          85.71            60                50            75     25                         100                  100                   0
  **Ceftizoxime**       13.51             20                0                   62.5              75          85.71            60                50            75     50                         100                  100                   0
  **Penicillin**        37.83             \-                30                  \-                \-          \-               \-                100           100    100                        100                  \-                    \-
  **Oxacillin**         48.64             \-                \-                  \-                \-          \-               \-                50            75     75                         100                  \-                    \-
  **Ampicillin**        \-                75                \-                  \-                \-          \-               \-                \-            \-     \-                         33.33                \-                    100
  **Ceftazidime**       8.1               20                \-                  100               100         85.71            25                \-            \-     \-                         100                  100                   0

5. Discussions {#sec61979}
==============

Bacterial meningitis is still one of the main health problems in children and newborns ([@A17616R2], [@A17616R3]). Etiological pathogens of meningitis are relatively diverse ([@A17616R8]). Most researchers have introduced *S. pneumoniae*, *H. influenzae* type b, and *N. meningitidis* as the main pathogens of the bacterial meningitis especially in childhood ([@A17616R6]). According to previous studies, prevalence of these pathogens can be different based on time, geographical area, and patient\'s age ([@A17616R3], [@A17616R18]). In an extensive study regarding the etiology of acute bacterial meningitis in some of the third world countries, Laxer and Marks reported *S. pneumoniae*as the most prevalent pathogen in children ([@A17616R11]). We found that the most prevalent organisms isolated from CSF were *S. pneumoniae*, *H. influenzae* type b, *N. meningitidis*, and *Serratia*spp., respectively. This finding is in close accordance with studies performed in countries where meningitis vaccine is not administered ([@A17616R11], [@A17616R19]). Meanwhile, according to the results of previous studies conducted in other areas of Iran, *S. pneumoniae*and *H. influenzae* type b were the main bacteria isolated from CSF, respectively. Nevertheless, a report in Turkey showed that *N. meningitidis* serogroup W135 was the dominant organism isolated from children with bacterial meningitis ([@A17616R20]). Moreover, recent studies indicated that outbreak level of *S. pneumoniae*, *H. influenzae* type b, and *N. meningitidis* significantly has reduced in some developed countries due to the administration of vaccines ([@A17616R9], [@A17616R10], [@A17616R13], [@A17616R21]). Although, *Listeria monocytogenes* and *Streptococcus agalactiae* are discussed as the important pathogens of bacterial meningitis in other areas except Iran ([@A17616R22]-[@A17616R24]); these bacteria were not isolated from CSF cultures in our study. It is not clearly known, whether these bacteria are not truly prevalent in our country or this is due to the lack of standard techniques required for their isolation. Furthermore, previous prescription of antibiotics leads to false negative results in culture and a decrease in the sensitivity of culture techniques, which may also affect our results. In this study, we investigated only culture-positive bacterial meningitis in children with bacterial meningitis symptoms and those with negative results in cultures were excluded. As shows in [Table 3](#tbl15814){ref-type="table"}, the antimicrobial susceptibility testing of the isolates demonstrated that *S. pneumoniae*had high resistance against penicillin. Moreover, these isolates had intermediate resistance against the third generation cephalosporins. These results represent an alarming and disturbing rate of resistant pneumococcus species in northwest Iran. Yet, resistance against vancomycin was not reported in our study, except one isolate of viridans *Streptococcus* as well as one *Enterococcus* species. In addition, the results indicated that the resistance of *H. influenzae* isolates against the third generation cephalosporins was considerable and about one third of the isolated strains were resistant against rifampicin, but susceptible to imipenem. Regarding *N. meningitidis*, no resistance was reported against cephalosporins and there was only resistance against penicillin. Other Gram-negative bacteria had relatively high resistance against aminoglycosides and β-lactams. [Table 3](#tbl15814){ref-type="table"} shows the frequency distribution of antimicrobial resistance of the main isolated bacteria against used antibiotics.

Blood culture is valuable to detect the causative organism and establish susceptibility patterns if CSF cultures have negative results or be unavailable. However, blood culture positivity differs for each causative organism ([@A17616R24]). In present study, blood culture was effective in 15% of samples, where the most prevalent organism isolated from blood culture of patients was *Haemophilus influenzae*type b.

Finally, our study revealed that emergence of resistant *S. pneumoniae*and *H. influenzae* strains needs continuous monitoring of antibiotic susceptibility patterns of clinical isolates for the appropriate selection of empirical therapy. Moreover, our results indicated that vaccination against *S. pneumoniae*and *H. influenzae* type b seems to be necessary.

The authors wish to thank Dr. Solmaz Nikvash, Mrs. Maryam Rasouli, Mr. Mohammad Reza Afghan and Mr. Jaber Kamran the microbiology laboratory staff at the Children Hospital, for their kind supports.
